HUAHUI HEALTH

Founded in 2015, Huahui Health is dedicated to the discovery, development, manufacturing, and commercialization of innovative therapies to fulfill unmet medical needs across the globe. Based on the paradigm-shifting discovery of NTCP by the founder of Huahui Health, Dr. Wenhui Li, the company has developed novel drug candidates for hepatitis B and D in hopes of achieving the ambitious goal of a functional cure. Leveraging outstanding competence and capabilities in discovery, early development, and antibody engineering, Huahui Health has further expanded its pipeline to include several "First-in-Class" and "Best-in-Class" drug candidates in virology and oncology... We understand that privacy is important to you. We are committed to handling your personal information with discretion and transparency. When we say "our company", "we", "Huahui" or "our", we are referring to Huahui Health, Ltd. and its affiliates.

Also known as: Huahui Health Ltd.

Primary location: Beijing China